Assignee
SHANGHAI XUNHE PHARMACEUTICAL TECH CO LTD
CN·3 granted patents·2 pending applications·5 citations·filing 2018–2023
Top patents by PatentIndex Score
5 records- 0184US10464927B22,4-disubstituted pyrimidines as CDK inhibitorsSHANGHAI XUNHE PHARMACEUTICAL TECH CO LTD·Filed 2018·Granted Nov 5, 2019·5 cites·7 claims
- 0258US11814405B2Pyridine sulfonamide phosphate compound, preparation method therefor, and use thereofSHANGHAI XUNHE PHARMACEUTICAL TECH CO LTD·Filed 2022·Granted Nov 14, 2023·0 cites·8 claims
- 0358US2024132473A1Sulfoximide substituted indazole irak4 kinase inhibitor, preparation method thereof and use thereofSHANGHAI XUNHE PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 0450US2022009951A1Torsemide phosphate prodrug, preparation method and composition thereofSHANGHAI XUNHE PHARMACEUTICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 0548US10351578B2Heterocyclic-substituted pyridinopyrimidinone derivative as CDK inhibitor and use thereofSHANGHAI XUNHE PHARMACEUTICAL TECH CO LTD·Filed 2018·Granted Jul 16, 2019·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI XUNHE PHARMACEUTICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →